[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fe9cboAc98uRnvOyjV284KFgNxyCUIUPo-t8pKm6O6ZM":3},{"code":4,"msg":5,"data":6},200,"操作成功",{"id":7,"title":8,"content":9,"digest":10,"source":10,"coverPath":11,"thumbsCoverPath":12,"isTop":13,"isShow":14,"baseClick":13,"clickCount":15,"createTime":16,"typeId":17,"isNewest":18,"newsInfoTypeRespVo":19,"voiceUrl":22,"voiceSize":23,"taskId":24,"releaseTime":25,"titleEn":26,"contentEn":27,"voiceUrlEn":28,"taskIdEn":29,"voiceSizeEn":30},2055,"全国首例！侵入式脑机接口让视障患者复明，这项临床试验在湖南取得重大突破","\u003Cp>\u003Cspan style=\"font-size: 18px;\">2026 年 6 月 6 日，中南大学湘雅医院传来喜讯，该院许惠卓教授团队完成\u003C\u002Fspan>\u003Cspan style=\"background-color: rgba(0, 0, 0, 0); font-size: 18px;\">全国首例侵入式脑机接口视觉重建临床试验\u003C\u002Fspan>\u003Cspan style=\"font-size: 18px;\">，帮助一名失明患者成功重建视觉功能，取得重大医学突破。此次试验针对视网膜色素变性这类退行性眼病，该病症会造成感光细胞不可逆退化，传统治疗方式难以奏效。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size: 18px;\">团队自主研发的 IMIE 智能视网膜系统是本次突破的核心。该系统借助外置摄像设备采集画面，将视觉信息转化为电信号，再通过眼内植入装置直接刺激眼底神经，以此重建视觉通路。其搭载的国产首创 256 通道柔性电极阵列，通道数量与视觉分辨能力远超国际主流的 60 通道同类产品，技术水平跻身国际先进行列。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size: 18px;\">目前受试者术后恢复状态良好，可感知明暗光点与物体轮廓，顺利辨认 E 字视力表标识，实测视力达 0.03，峰值可达 0.1，还能在无人搀扶的情况下自主完成室内行走、穿行房门等动作。不过这种仿生视觉和天然视觉存在差距，受试者仍需为期一年的持续训练，逐步建立全新视觉认知，现阶段也尚未实现完全生活自理。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size: 18px;\">这项成果拥有完全自主知识产权，不仅为不可逆失明患者开辟了全新治疗路径，也彰显了我国高端医疗器械自主创新的实力。接下来，科研团队将逐步扩大试验受试者范围，持续优化视觉编码策略与康复方案，推进产品迭代升级，力争早日完成产品注册审评，让这项技术惠及更多视障人群。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>【新闻来源】网易新闻  https:\u002F\u002Fwww.163.com\u002Fdy\u002Farticle\u002FKUODBGSF0550HXM1.html\u003C\u002Fp>\u003Cp>（本网转发此文章，旨在为读者提供更多的信息资讯，所涉内容不构成投资、消费建议。文章事实如有疑问，请与有关方核实，文章观点非本网观点，仅供读者参考。）\u003C\u002Fp>","","https:\u002F\u002Fimage.51xinwei.com\u002F2026\u002F06\u002F6e790fa24b1f42428ff0b02f7c6ce013\u002F芯位视野.png","https:\u002F\u002Fimage.51xinwei.com\u002F2026\u002F06\u002Fthumbs\u002F6e790fa24b1f42428ff0b02f7c6ce013\u002F芯位视野.png",0,1,46,"2026-06-10 11:23",2,false,{"id":17,"name":20,"enName":21},"芯位视野","Xinwei Vision","https:\u002F\u002Fxinwei-dev-test.oss-cn-shenzhen.aliyuncs.com\u002Fintelligent\u002Faudio%3A344ef2e7-d98c-4430-8d2f-430e202a3e93%3A0.wav?Expires=1781065978&OSSAccessKeyId=LTAI5tNvY2RkKjZw4LLWsrPK&Signature=m7QKfm%2FxdIsTOFyUW8z5NUg6jpM%3D",3361032,"344ef2e7-d98c-4430-8d2f-430e202a3e93","2026-06-10 11:17","National First! Invasive Brain-Computer Interface Restores Vision to Visually Impaired Patient, This Clinical Trial Achieves Major Breakthrough in Hunan","\u003Cp>\u003Cspan style=\"font-size: 18px;\">On June 6, 2026, Xiangya Hospital of Central South University announced joyful news. Professor Xu Huizhuo's team from the hospital completed\u003C\u002Fspan>\u003Cspan style=\"background-color: rgba(0, 0, 0,要积极 0); font-size: 18px;\">the nation's first clinical trial of visual reconstruction using an invasive brain-computer interface\u003C\u002Fspan>\u003Cspan style=\"font-size: 18px;\">, successfully helping a blind patient restore visual function and achieving a major medical breakthrough. This trial targeted degenerative eye diseases such as retinitis pigmentosa, which causes irreversible degeneration of photoreceptor cells, making traditional treatments ineffective.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size: 18px;\">The core of this breakthrough is the independently developed IMIE Intelligent Retinal System. The system uses an external camera device to capture images, converts visual information into electrical signals, and then directly stimulates the fundus nerves through an intraocular implant to reconstruct the visual pathway. Its domestically pioneered 256-channel flexible electrode array boasts a channel count and visual resolution far surpassing the internationally mainstream 60-channel counterparts, placing its technical level at the forefront internationally.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size: 18px;\">Currently, the participant is recovering well post-operation. They can perceive light and dark spots and object outlines, successfully identify indicators on an E-chart visual acuity chart, with measured visual acuity reaching 0.03 and peaking at 0.1. They can also independently perform actions like indoor walking and passing through doorways without assistance. However, there remains a gap between this bionic vision and natural vision. The participant still requires ongoing training for one year to gradually establish a new visual cognition, and complete self-sufficiency in daily life has not yet been achieved at this stage.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size: 18px;\">This achievement possesses full independent intellectual property rights. It not only opens a new treatment pathway for patients with irreversible blindness but also demonstrates the strength of China's independent innovation in high-end medical devices. Next, the research team will gradually expand the scope of trial participants, continuously optimize visual encoding strategies and rehabilitation plans, promote product iteration and upgrades, and strive to complete product registration and evaluation as soon as possible, allowing this technology to benefit more visually impaired individuals.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>【News Source】NetEase News  https:\u002F\u002Fwww.163.com\u002Fdy\u002Farticle\u002FKUODBGSF0550HXM1.html\u003C\u002Fp>\u003Cp>(This website reposts this article to provide readers with more information. The content does not constitute investment or consumption advice. If there are questions regarding the facts in the article, please verify with relevant parties. The views in the article are not those of this website and are for readers' reference only.)\u003C\u002Fp>","https:\u002F\u002Fxinwei-dev-test.oss-cn-shenzhen.aliyuncs.com\u002Fintelligent\u002Faudio%3A3b5a55f2-95f6-4306-9e7f-91fd077c568f%3A0.wav?Expires=1781065978&OSSAccessKeyId=LTAI5tNvY2RkKjZw4LLWsrPK&Signature=VEuJMtJVz7nMif%2B4rAhzMPv9XO8%3D","3b5a55f2-95f6-4306-9e7f-91fd077c568f",4860272]